Skip to main content

Rheumatology Specialty Medications

MedRx Infusion dispenses the infusions, injections and tablets rheumatologists prescribe for rheumatoid arthritis, spondyloarthritis, lupus, vasculitis, gout and osteoporosis. With the prescriber's approval for home therapy, infusions are given at home by a licensed nurse; injections and tablets are shipped to the patient's door at no charge.

Rheumatoid arthritis infusion

MedRx Infusion dispenses Remicade (infliximab), Simponi Aria (golimumab), Orencia (abatacept), Actemra (tocilizumab) and Rituxan (rituximab), the intravenous medications prescribed for rheumatoid arthritis, and a licensed nurse can give the infusion at home when the rheumatologist approves home therapy. Licensed in 43 states, the District of Columbia and Puerto Rico, MedRx Infusion Clinical Pharmacy is a specialty pharmacy and home infusion pharmacy; therapy starts when the rheumatology practice sends a referral.

Each is a biologic that acts on part of the immune response behind joint inflammation: Remicade and Simponi Aria block TNF, Orencia blocks T-cell activation, Actemra blocks the IL-6 receptor, and Rituxan helps the body remove B cells. MedRx also dispenses the self-injected and oral rheumatology medications. See biologic infusions at home.

Rheumatology medications MedRx dispenses, by condition

Each medication is approved for its own conditions, ages and treatment history, and the rheumatologist determines which is appropriate.

  • Rheumatoid arthritis: intravenously, Remicade and its biosimilars Inflectra (infliximab-dyyb), Avsola (infliximab-axxq) and Renflexis (infliximab-abda), Simponi Aria, Orencia, Actemra and its biosimilar Tyenne (tocilizumab-aazg), and Rituxan and its biosimilar Ruxience (rituximab-pvvr); by injection, Humira (adalimumab), Enbrel (etanercept), Cimzia (certolizumab pegol), Kevzara (sarilumab), Simponi, Orencia, Actemra and methotrexate; by mouth, Rinvoq (upadacitinib) and Xeljanz (tofacitinib), after TNF blocker treatment.
  • Psoriatic arthritis: Remicade, Simponi Aria and Orencia intravenously; Humira, Enbrel, Cimzia, Simponi, Cosentyx (secukinumab), Taltz (ixekizumab) and Bimzelx (bimekizumab-bkzx) by injection; Rinvoq, Xeljanz and Otezla (apremilast) by mouth.
  • Ankylosing spondylitis: Remicade and Simponi Aria intravenously; Humira, Enbrel, Cimzia, Simponi, Cosentyx, Taltz and Bimzelx by injection; Rinvoq and Xeljanz by mouth. Cimzia, Cosentyx, Taltz, Bimzelx and Rinvoq are also approved for non-radiographic axial spondyloarthritis.
  • Juvenile idiopathic arthritis: for the polyarticular form, Simponi Aria, Orencia, Actemra, Humira, Enbrel, Cimzia, Kevzara, Rinvoq, Xeljanz and methotrexate; for the systemic form, Actemra and Ilaris (canakinumab); for enthesitis-related arthritis, Cosentyx.
  • Giant cell arteritis and polymyalgia rheumatica: Actemra and Rinvoq for giant cell arteritis; Kevzara for polymyalgia rheumatica.
  • Granulomatosis with polyangiitis and microscopic polyangiitis (ANCA vasculitis): Rituxan, with glucocorticoids.
  • Systemic sclerosis-associated interstitial lung disease: Actemra, by subcutaneous injection only.
  • Systemic lupus erythematosus and lupus nephritis: Benlysta (belimumab) for both and Saphnelo (anifrolumab-fnia) for lupus, intravenously or by subcutaneous injection, with standard lupus treatment.
  • Gout: Krystexxa (pegloticase), intravenously, for chronic gout when uric acid-lowering tablets did not control it or cannot be taken; Ilaris for gout flares when NSAIDs, colchicine and repeated steroid courses are not suitable.
  • Periodic fever syndromes and Still's disease: Ilaris, for cryopyrin-associated periodic syndromes (CAPS), TRAPS, HIDS/MKD, familial Mediterranean fever and Still's disease.
  • Oral ulcers of Behçet's disease: Otezla.
  • Osteoporosis after menopause: Reclast (zoledronic acid) and ibandronate, given into a vein; Prolia (denosumab) and its biosimilar Jubbonti (denosumab-bbdz), Evenity (romosozumab-aqqg) and Forteo (teriparatide), by subcutaneous injection. Reclast is also approved to prevent it.
  • Osteoporosis in men and osteoporosis from long-term glucocorticoids: Reclast, Prolia and Forteo.
  • Paget's disease of bone: Reclast.

Where the medication is given

When the rheumatologist approves home therapy, MedRx Infusion sends a skilled, trusted and licensed nurse from an accredited nursing agency to give infusions such as Remicade, Orencia, Actemra, Rituxan, Benlysta or Reclast, and to monitor vital signs and adverse reactions until the infusion is complete. Practices that infuse in the office can have the medication delivered there. See home infusion nursing.

Self-injected medications such as Humira, Enbrel and Forteo are used at home by the patient or a caregiver once trained. Some labels limit where, or by whom, a medication is given:

  • Krystexxa is given in a healthcare setting by providers prepared to manage serious allergic reactions, as its label requires. MedRx Infusion dispenses it for the setting where it is given.
  • Cosentyx's intravenous form is given only by a healthcare professional in a healthcare setting.
  • Prolia, Evenity, Ilaris and methotrexate injection are given by a healthcare professional. The prescriber determines where.

How to refer a rheumatology patient

  1. For arthritis, lupus, vasculitis and gout medications, the practice completes the Rheumatology referral form (PDF), whose two pages list medications from A to R and from R to Z. For osteoporosis, it uses the Osteoporosis referral form (PDF). Both can be completed online on the Quick Referral page and printed.
  2. The office faxes the form to (844) 671-2601, together with recent clinical notes and laboratory results, the ICD-10 diagnosis code and the treatments already tried; the rheumatology form also asks for the date of a negative TB test. For a medication the form does not print, the office can call (844) 671-2600.
  3. The prescriber marks where the medication is to be given (the patient's home, the prescriber's office or another site) and can have MedRx hold the shipment until notified.
  4. MedRx's intake team verifies benefits and obtains any prior authorization the plan requires.
  5. The order, with an anaphylaxis kit, diluents, flushes and supplies as needed, is delivered to the patient's door at no charge. Next-day delivery is available; timing varies by location. A MedRx pharmacist is available 24 hours a day, 7 days a week.

Insurance and cost

Plans often require prior authorization for these medications. Several labels apply after earlier treatment did not work well enough, and the referral form records the medications already tried. MedRx's intake team confirms benefits before the first delivery.

Where cost is a barrier, MedRx helps the patient look for and apply to copay assistance, grant programs and other financial aid, including manufacturers' programs such as Orencia On Call, Amgen SupportPlus (Enbrel, Otezla, Prolia and Evenity), J&J withMe (Remicade and Simponi), Together with Benlysta and Genentech's programs for Actemra and Rituxan. Each medication's page names its program.

Key facts

Organization
MedRx Infusion Clinical Pharmacy
What we do
A home infusion pharmacy and specialty pharmacy, with infusion nurses who visit patients at home and a pharmacist on call 24 hours a day, 7 days a week.
Where
Pharmacy at 417 N Oak St, Inglewood, CA 90302. Licensed in 43 states, the District of Columbia and Puerto Rico. See every place we serve
Accreditation
URAC (Specialty Pharmacy) and ACHC (Accreditation Commission for Health Care).
Phone, 24 hours
(844) 671-2600
Fax
(844) 671-2601

Accurate as of

Questions about rheumatology medications

01What IV infusions are used for rheumatoid arthritis?

The rheumatologist chooses the infusion for each patient; no single one suits everyone. The intravenous options MedRx dispenses for rheumatoid arthritis are Remicade or one of its biosimilars and Simponi Aria, each used with methotrexate; Orencia; Actemra, when DMARDs did not work well enough; and Rituxan, with methotrexate, after a TNF blocker did not work well enough.

02Is Remicade used for rheumatoid arthritis?

Yes. Remicade is FDA-approved for adults with moderately to severely active rheumatoid arthritis, used together with methotrexate, and is infused into a vein by a healthcare professional, as are its biosimilars.

03Can rheumatoid arthritis infusions be given at home?

Yes, when the rheumatologist approves home therapy. MedRx delivers the medication and supplies, and a nurse from an accredited nursing agency administers the infusion, monitoring the patient until it ends.

04What is a Reclast infusion?

Reclast is zoledronic acid, a bisphosphonate that slows the cells that break down bone, given as an infusion into a vein. It is approved to treat osteoporosis after menopause, in men and from long-term glucocorticoid use, to prevent osteoporosis after menopause, and for Paget's disease of bone. MedRx dispenses it, and a nurse can give it at home when the prescriber approves.

Medications we fill

Each has its own page: what it is approved for, how it is given, and how to start. See every medication we fill.

Send a referral

Intake handles benefits investigation, prior authorization and scheduling.

Send a referral

Phone

(844) 671-2600

Speak with an intake coordinator

Fax

(844) 671-2601

Send a completed referral form

Forms

Referral forms

Specialty-specific PDFs